ストックスクリーナーアプリを入手
8.35
3.80%
-0.33
前日終値:
$8.68
開ける：
$8.86
24時間の取引高:
1.12M
Relative Volume:
0.65
時価総額：
$710.29M
収益：
-
当期純損益:
$-43.16M
株価収益率:
-15.18
EPS:
-0.55
ネットキャッシュフロー:
$-29.31M
1週間 パフォーマンス:
-2.00%
1か月 パフォーマンス:
-15.23%
6か月 パフォーマンス:
+31.50%
1年 パフォーマンス:
+64.37%
1日の値動き範囲:
$8.33
$8.9242
1週間の範囲:
$8.33
$9.2023
52週間の値動き範囲:
$3.25
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
名前
Anavex Life Sciences Corporation
セクター
電話
844-689-3939
住所
630 5TH AVENUE, NEW YORK
AVXL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
8.35 | 710.29M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-12-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-09-23 | 開始されました | BTIG Research | Buy |
| 2020-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-28 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-02-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-18 | 開始されました | Janney | Buy |
| 2018-05-16 | 再開されました | Maxim Group | Buy |
| 2018-03-08 | 開始されました | ROTH Capital | Buy |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
| 2017-09-29 | 再開されました | Noble Financial | Buy |
| 2017-02-07 | 開始されました | Noble Financial | Buy |
| 2016-03-29 | 開始されました | FBR Capital | Outperform |
すべてを表示
Anavex Life Sciences Corporation (AVXL) 最新ニュース
Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
UPCOMING AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Anavex Life Sciences (NASDAQ:AVXL) Given "Buy" Rating at HC Wainwright - MarketBeat
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit - ACCESS Newswire
Anavex Life Sciences Corporation Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAVXL - ACCESS Newswire
Wainwright maintains $42 target on Anavex Life Sciences stock By Investing.com - Investing.com Nigeria
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Wainwright maintains $42 target on Anavex Life Sciences stock - Investing.com India
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Anavex Life Sciences (NASDAQ:AVXL) Posts Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Earnings call transcript: Anavex Life Sciences Q4 2024 sees net loss, stock rises - MSN
Anavex: Looking At Different Statistical Approaches Before EMA Opinion (NASDAQ:AVXL) - Seeking Alpha
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Call Transcript - MSN
Anavex Life Sciences Reports Higher Quarterly Loss Amid R&D Focus - TipRanks
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot - mySA
Anavex Life Sciences Corp. (AVXL) reports earnings - Quartz
Anavex Life Sciences Corp. Reports Earnings Results for the First Quarter Ended December 31, 2024 - Marketscreener.com
ANAVEX LIFE SCIENCES CORP. SEC 10-Q Report - TradingView
Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update - The Manila Times
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot -February 12, 2025 at 07:40 am EST - Marketscreener.com
Analytical Lens: Exploring Anavex Life Sciences Corporation (AVXL)’s Financial Story Through Ratios - The Dwinnex
Anavex Life Sciences Corporation (AVXL) receives a Neutral rating from Cantor Fitzgerald - Knox Daily
Anavex Life Sciences Corporation (AVXL) Stock: Assessing the Risk and Reward - The News Heater
Anavex Life Sciences (AVXL) to Release Quarterly Earnings on Wednesday - MarketBeat
Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025 - The Manila Times
Anavex Life Sciences Corp. Announces Financial Results Conference Call for First Fiscal Quarter 2025 - Nasdaq
Anavex Q1 2025 Earnings: Strategic Growth Updates Coming February 12 - StockTitan
AVXL DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline - ACCESS Newswire
Anavex Life Sciences (AVXL) to Release Earnings on Wednesday - MarketBeat
JPMorgan Chase & Co. Acquires 1,191 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Receives "Buy" Rating from D. Boral Capital - MarketBeat
HC Wainwright Reaffirms Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Jim Cramer on Anavex Life Sciences Corp. (AVXL): ‘It’s A Good Spec’ - Yahoo Finance
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from D. Boral Capital - Defense World
Anavex Life Sciences Secures New Patent For ANAVEX®2-73 - Evrim Ağacı
NASDAQ: AVXL Lawsuit Update: Investors Who Lost Money With Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) Should Contact the Shareholders Foundation - ACCESS Newswire
Anavex Life Sciences Secures New U.S. Patent For ANAVEX 2-73 Or Blarcamesine - RTTNews
Anavex Life Sciences Corporation (AVXL) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):